PT-141 (Bremelanotide) Overview
PT-141 (Bremelanotide) is a synthetic peptide analogue of α-MSH developed by Palatin Technologies. It stimulates melanocortin and xanthine receptors to enhance libido, sexual desire, and sexual function in both men and women. PT-141 may also positively affect mood and depressive symptoms.
Peptide Profile
- Name: PT-141 (Bremelanotide)
- Main Function: Enhances sexual function and libido
- Mechanism: Stimulates melanocortin receptors, indirectly influencing sexual arousal
Key Benefits
- Enhances libido and sexual desire in both men and women
- Improves erectile function and sexual satisfaction
- Enhances sexual sensations and orgasm quality
- Supports confidence and self-esteem during sexual activity
- Potential positive effects on mood and stress (including PTSD-related symptoms)
- Rapid onset of action, effects observed within hours
Research & Applications
- Clinical trials in men and women show improved sexual desire, satisfaction, and activity
- Effective for hypersexual disorder, erectile dysfunction, and other sexual dysfunctions
- Studied for additional benefits including mood, chronic pain, and hormonal imbalance
Possible Side Effects
- Mild headaches or pressure sensations
- Nausea
- Temporary skin irritation at the injection site
- Possible transient increase in blood pressure
Note: Informational content only.